Dementia in patients with diabetes mellitus
Keywords:
blood glucose, dementia, geriatric, type II diabetes mellitusAbstract
The role of diabetes mellitus in neurodegeneration has been confirmed by neuroimaging and neuropathological studies. Apart from causing schizophrenia, chronic exposure to hyperglycemia may worsen cognitive function and cause significant cognitive disorders, such as Alzheimer’s and dementia. An 81-year-old woman was consulted to the Psychiatry department with fatigue and forgetfulness. She was found unconscious in her room. In the emergency room, her blood glucose level was 30 mg/dl with type 2 diabetes since 2012. She was able to pronounce her name correctly but forgot her age, said that she was in her home, the examinations were in the morning, and the name of her ex-employee who accompanied her and said that she already had breakfast, could repeat the names of 3 objects given. She was asked to repeat in 1 minute can only say 1 name of the object correctly, cannot count the subtraction several times. The patient correctly pronounced the name of the object shown to her, but cannot fold paper, write sentences, or draw. Psychiatrist give her Avram 1x5 mg and Aricept 1x5 mg also provided assistance, family education, and reminiscence therapy, and she had 8 units of Novorapid injection subcutaneously after a meal from the geriatrist.
Downloads
References
Alexopoulos, G. S., Raue, P., & Areán, P. (2003). Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. The American journal of geriatric psychiatry, 11(1), 46-52. https://doi.org/10.1097/00019442-200301000-00007
Bellamy, L., Casas, J. P., Hingorani, A. D., & Williams, D. (2009). Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The lancet, 373(9677), 1773-1779. https://doi.org/10.1016/S0140-6736(09)60731-5
Biessels, G. J., Strachan, M. W., Visseren, F. L., Kappelle, L. J., & Whitmer, R. A. (2014). Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. The lancet Diabetes & endocrinology, 2(3), 246-255. https://doi.org/10.1016/S2213-8587(13)70088-3
Danaei, G., Lawes, C. M., Vander Hoorn, S., Murray, C. J., & Ezzati, M. (2006). Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. The Lancet, 368(9548), 1651-1659. https://doi.org/10.1016/S0140-6736(06)69700-6
Goyal, R., & Jialal, I. (2022). Diabetes Mellitus Type 2.[Updated 2021 Sep 28]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
Hirsch, I. B., & Brownlee, M. (2005). Should minimal blood glucose variability become the gold standard of glycemic control?. Journal of Diabetes and its Complications, 19(3), 178-181. https://doi.org/10.1016/j.jdiacomp.2004.10.001
Holman, N., Knighton, P., Kar, P., O'Keefe, J., Curley, M., Weaver, A., ... & Valabhji, J. (2020). Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. The lancet Diabetes & endocrinology, 8(10), 823-833. https://doi.org/10.1016/S2213-8587(20)30271-0
Kemenkes RI. (2018). Profil Kesehatan Indonesia tahun 2017. Kementrian kesehatan RI.
Lee, H. J., Seo, H. I., Cha, H. Y., Yang, Y. J., Kwon, S. H., & Yang, S. J. (2018). Diabetes and Alzheimer's disease: mechanisms and nutritional aspects. Clinical nutrition research, 7(4), 229-240.
Lyketsos, C. G., Carrillo, M. C., Ryan, J. M., Khachaturian, A. S., Trzepacz, P., Amatniek, J., ... & Miller, D. S. (2011). Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimer's & Dementia, 7(5), 532-539. https://doi.org/10.1016/j.jalz.2011.05.2410
Marc, L. G., Raue, P. J., & Bruce, M. L. (2008). Screening performance of the 15-item geriatric depression scale in a diverse elderly home care population. The American Journal of Geriatric Psychiatry, 16(11), 914-921. https://doi.org/10.1097/JGP.0b013e318186bd67
Matthews, F. E., & Dening, T. (2002). Prevalence of dementia in institutional care. The Lancet, 360(9328), 225-226. https://doi.org/10.1016/S0140-6736(02)09461-8
Moheet, A., Mangia, S., & Seaquist, E. R. (2015). Impact of diabetes on cognitive function and brain structure. Annals of the New York Academy of Sciences, 1353(1), 60-71.
Mouri, M., & Badireddy, M. (2022). Hyperglycemia. In StatPearls [Internet]. StatPearls Publishing.
Okaniawan, P. E. P., & Agustini, N. N. M. (2021). Penurunan Fungsi Kognitif Akibat Diabetes Melitus. Ganesha Medicina, 1(1), 28-37.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013). The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's & dementia, 9(1), 63-75. https://doi.org/10.1016/j.jalz.2012.11.007
Saedi, E., Gheini, M. R., Faiz, F., & Arami, M. A. (2016). Diabetes mellitus and cognitive impairments. World journal of diabetes, 7(17), 412.
Saraswati, P. A. I. ., Gunawan, I. M. K., & Budiyasa, D. G. A. (2021). Overview of glomerulus filtration in type 2 of diabetes mellitus at Sanjiwani Gianyar hospital year of 2018-2019. International Journal of Health & Medical Sciences, 4(1), 50-55. https://doi.org/10.31295/ijhms.v4n1.726
Tsalissavrina, I., Tritisari, K. P., Handayani, D., Kusumastuty, I., Ariestiningsih, A. D., & Armetristi, F. (2018). Hubungan lama terdiagnosa diabetes dan kadar glukosa darah dengan fungsi kognitif penderita diabetes tipe 2 di Jawa Timur. AcTion: Aceh Nutrition Journal, 3(1), 28-33.
Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., ... & Newsholme, P. (2015). Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease. Mediators of inflammation, 2015.
Yoon, K. H., Lee, J. H., Kim, J. W., Cho, J. H., Choi, Y. H., Ko, S. H., ... & Son, H. Y. (2006). Epidemic obesity and type 2 diabetes in Asia. The Lancet, 368(9548), 1681-1688. https://doi.org/10.1016/S0140-6736(06)69703-1
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health & medical sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health & Medical Sciences (IJHMS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHMS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHMS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
